These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 16398841)

  • 1. Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism.
    Geelhoed EA; Lewis B; Hounsome D; O'leary P
    J Paediatr Child Health; 2005 Nov; 41(11):575-9. PubMed ID: 16398841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A cost-benefit evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism].
    Gu X; Wang J; Ye J; Cheng X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):147-9. PubMed ID: 11860921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening for phenylketonuria and congenital hypothyroidism in 5.8 million neonates in China].
    Gu XF; Wang ZG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Mar; 38(2):99-102. PubMed ID: 15061917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya.
    Sladkevicius E; Pollitt RJ; Mgadmi A; Guest JF
    Appl Health Econ Health Policy; 2010; 8(6):407-20. PubMed ID: 21043542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost/benefit study of the neonatal detection of phenylketonuria and hypothyroidism].
    Dhondt JL; Farriaux JP; Lebrun T; Sailly JC
    Pediatrie; 1988; 43(4):345-8. PubMed ID: 3138627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-benefit analysis of a prenatal preventive programme against congenital syphilis.
    Stray-Pedersen B
    NIPH Ann; 1980 May; 3(1):57-66. PubMed ID: 6779243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of tandem mass spectrometry screening in California.
    Feuchtbaum L; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S280-6. PubMed ID: 16735254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple positive results during a neonatal screening program: a retrospective analysis of incidence, clinical implications and outcomes.
    Zaffanello M; Maffeis C; Zamboni G
    J Perinat Med; 2005; 33(3):246-51. PubMed ID: 15914349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for PKU and congenital hypothyroidism in Latvia.
    Lugovska R; Vevere P; Andrusaite R; Kornejeva A
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():52-3. PubMed ID: 11400783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [National screening for phenylketonuria, congenital hypothyroidism and congenital adrenal hyperplasia].
    Osório RV; Vilarinho L; Soares JP
    Acta Med Port; 1992 Mar; 5(3):131-4. PubMed ID: 1595380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal screening program in Thailand.
    Charoensiriwatana W; Janejai N; Boonwanich W; Krasao P; Chaisomchit S; Waiyasilp S
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():94-100. PubMed ID: 15906708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal screening of phenylketonuria and congenital hypothyroidism in China.
    Fan GX; Jun Y; Rui-guan C
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():17-9. PubMed ID: 11400761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening in Zhejiang, China.
    Maitusong R; Japaer R; Zhao ZY; Yang RL; Huang XL; Mao HQ
    Chin Med J (Engl); 2012 Feb; 125(4):702-4. PubMed ID: 22490499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal screening for congenital hypothyroidism and phenylketonuria at Siriraj Hospital, Mahidol University, Bangkok, Thailand--a pilot study.
    Wasant P; Liammongkolkul S; Srisawat C
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():33-7. PubMed ID: 11400774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Newborn Screening for Phenylketonuria and Congenital Hypothyroidism.
    Appelberg K; Sörensen L; Zetterström RH; Henriksson M; Wedell A; Levin LÅ
    J Pediatr; 2023 May; 256():38-43.e3. PubMed ID: 36495999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of cost-benefit ratio of neonatal screening procedure for phenylketonuria and hypothyroidism.
    Dhondt JL; Farriaux JP; Sailly JC; Lebrun T
    J Inherit Metab Dis; 1991; 14(4):633-9. PubMed ID: 1749228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of tandem mass spectrometry newborn screening in Australia.
    Norman R; Haas M; Chaplin M; Joy P; Wilcken B
    Pediatrics; 2009 Feb; 123(2):451-7. PubMed ID: 19171609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal screening for congenital hypothyroidism and phenylketonuria in China.
    Zhan JY; Qin YF; Zhao ZY
    World J Pediatr; 2009 May; 5(2):136-9. PubMed ID: 19718537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program.
    Lanting CI; van Tijn DA; Loeber JG; Vulsma T; de Vijlder JJ; Verkerk PH
    Pediatrics; 2005 Jul; 116(1):168-73. PubMed ID: 15995048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal screening program in Rajavithi Hospital, Thailand.
    Ratrisawadi V; Horpaopan S; Chotigeat U; Sangtawesin V; Kanjanapattanakul W; Ningsanond V; Sunthornthepvarakul T; Khooarmompatana S; Charoensiriwatana W
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():28-32. PubMed ID: 11400773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.